The recovery is visible; the funding test is still ahead. Acquisition timing explains much of reported growth, annual margins remain lower, and distributions exceed free cash. A three-route $50 anchor and limited expected cushion support HOLD until cash conversion strengthens or price offers a larger margin of safety.
Explicit analyst probabilities; values are not issuer forecasts.
| Scenario | Probability | 12-month value | vs $53.08 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 25% | $35.00 | −34% | Underlying activity and cash disappoint. | $2.50 normalized EPS ×14 |
| Base | 50% | $50.00 | −6% | Measured recovery; cash commitments limit the valuation premium. | Rounded mean of $52.70,$50.60,$46.67 routes |
| Bull | 25% | $74.00 | +39% | Core recovery and new businesses deliver stronger per-share returns. | $3.70 normalized EPS ×20 |
| Computed:25%×$35 +50%×$50 +25%×$74 = $52.25. Probabilities sum to100%. | |||||
| Signpost | Now (Q3 2026) | Green if | Red if | Next check |
|---|---|---|---|---|
| Acquisition-excluded revenue | ≈2% YoY | >3% on same basis | ≤0% | Q4 release /Jan2027 review |
| Adjusted EBITDA margin | 21.9% | ≥23% | <21% | Q4 release /Jan2027 review |
| FCF versus distributions | $828M vs$1,095M Q3 | FCF covers distributions | Widening funding gap | FY release /Jan2027 review |
| Net debt | $9.249B | ≤$9.249B with stronger cash | >$10B plus weaker margins | FY release /Jan2027 review |
| Capital investment | $1.835B YTD | FY≈$2.5B explained | Material unexplained overrun | FY release /Jan2027 review |
| Digital ARR | $1.04B | >10% reported annual growth | <5% annual growth | Q4 release /Jan2027 review |
| Kelvion | Pending H1 2027 | Disclosed return/funding plan | Cost rise or weak return case | Before closing /H1 2027 |
Q4/FY2026 release: January2027 analytical review window; future exact release date not verified.
We rate SLB HOLD with three-out-of-five conviction and High uncertainty. The reference price is $53.08, the October 26, 2026 close. Our base fair value is $50, rounded from the equal-weight average of three separately disclosed valuation routes. Their approximate $47–$53 range is a method comparison, not a statistical confidence interval. A probability-weighted scenario value of $52.25 sits slightly below the reference price. The current price therefore offers little compensation for a recovery that still has to become stronger cash generation.
The release-date trading window was positive. The October 23 close was 7.08% above the October 22 close, and the October 26 reference was 7.12% above that same pre-release close. These are calculated full-session windows from FMP prices. They include other market developments and do not prove that a single sentence in the release caused the move. We have verified the October 23 release date but have not assigned a precise release clock time from the SEC acceptance time or the conference-call appointment.
This episode deliberately investigates a different question from the prior Q2 presentation, which focused on a sharp price rise despite falling earnings. The Q3 question is whether the mix of acquired growth, improving activity and accelerating data-center revenue can support both distributions and another large acquisition. That makes the cash allocation and comparable-growth bridges more useful than repeating a chase-the-rally argument.
The retrieved 52-week range is $34.65–$60.46. It illustrates how much expectations can change before the operating story is settled. It does not establish where the stock should trade next. We require a 20% margin of safety against the $50 anchor, or roughly $40, before valuation alone would support a BUY with the operating thesis intact. Better evidence can raise the anchor; weaker evidence can lower it. The price checkpoint is a conditional discipline, not an automatic order.
| Reference | Value | Meaning |
|---|---|---|
| October 26 close | $53.08 | Dated market reference |
| Base fair value | $50 | Rounded average of three routes |
| Scenario weighted value | $52.25 | Assumed probabilities, not a forecast |
| Conditional entry checkpoint | $40 | 20% margin of safety |
| 52-week range | $34.65–$60.46 | Provider historical range |
Third-quarter revenue was $9.449 billion, up 5.84% from $8.928 billion a year earlier. Adjusted EBITDA was $2.067 billion versus $2.061 billion, essentially flat, while EPS excluding charges and credits fell from $0.69 to $0.64. GAAP diluted EPS was $0.49 versus $0.50. Revenue and earnings therefore tell different stories: SLB is recovering sequentially, but the annual comparison still shows pressure on the profit earned from each dollar of sales.
ChampionX is essential to interpreting the revenue increase. Its acquired businesses contributed $956 million this quarter versus $579 million in the prior-year reported period, which included two months of activity. The $377 million difference represents approximately 72% of SLB’s $521 million reported revenue increase. That arithmetic identifies the acquisition contribution; it does not attribute every remaining dollar to price or volume. Excluding the acquired businesses from both periods gives approximately 1.72% growth, consistent with the release’s rounded 2% description.
The company also supplies a different, pro forma comparison that assumes ChampionX was owned from the start of 2025. Against $9.229 billion on that basis, current revenue grew approximately 2.38%. The acquisition-excluded and pro forma calculations answer different questions and should not be mixed. The first removes acquired operations; the second includes a comparable full period. Both are substantially below headline growth, and both still show positive current progress.
The retrieved consensus record was $9.272 billion revenue and $0.617 EPS. Actuals exceeded those measures by approximately 1.91% and 3.73%. The EPS comparison uses the adjusted figure that the provider labels as actual, not GAAP EPS. A beat against that snapshot can coexist with weaker year-over-year profitability. We retain that distinction throughout the packet and avoid inventing a company revenue or EPS forecast where the release supplies none.
| Measure | Q3 2025 | Q3 2026 | Change |
|---|---|---|---|
| Revenue $M | 8,928 | 9,449 | +5.84% |
| Adjusted EBITDA $M | 2,061 | 2,067 | Essentially flat |
| Adjusted EPS | $0.69 | $0.64 | −7.25% |
| GAAP diluted EPS | $0.50 | $0.49 | −2% |
| ChampionX revenue $M | 579 | 956 | Two months versus three |
Production Systems delivered $4.000 billion of revenue and $646 million of pretax operating income. Its reported revenue rose 15% year over year, but the company describes approximately 5% growth excluding the acquisition effect. The segment benefits from production chemicals, artificial lift and SLB OneSubsea activity. Those exposures can extend an existing asset’s productive life, which differs economically from relying entirely on a new drilling campaign. The distinction helps explain why the portfolio can improve even when some drilling markets remain below last year.
Well Construction generated $2.888 billion of revenue and $475 million of pretax operating income. Reservoir Performance generated $1.634 billion and $266 million, respectively. Both recovered sequentially as Middle East activity improved, but both still reported roughly 3% lower year-over-year revenue and about 15% lower operating income. Their margins were 16.4% and 16.3%, below the prior-year levels. A rebound from a disrupted quarter is useful evidence, but it does not establish that prior margins have already returned.
Digital revenue was $693 million with $194 million of pretax operating income, a 28.0% margin. Revenue declined slightly sequentially as lower exploration-data sales offset improvement elsewhere. Platforms and Applications grew sequentially to $299 million and Digital Operations reached $163 million. These recurring and workflow-oriented activities deserve attention, but Digital also contains more variable exploration and services revenue. Treating the entire division as subscription software would overstate its recurring character.
Digital annualized recurring revenue was reported at $1.04 billion, with 13% growth stated by the issuer. Dividing the rounded $1.04 billion by the rounded $926 million comparator produces about 12.3%; that rounding difference is disclosed rather than silently changing the company’s reported growth rate. Data Center Solutions revenue grew 23% sequentially and 76% year over year, but a separate absolute revenue and profit figure is not supplied here. We do not assign the entire All Other segment to data centers or invent a standalone margin.
| Division | Revenue $M | Pretax profit $M | Margin |
|---|---|---|---|
| Digital | 693 | 194 | 28.0% |
| Reservoir Performance | 1,634 | 266 | 16.3% |
| Well Construction | 2,888 | 475 | 16.4% |
| Production Systems | 4,000 | 646 | 16.1% |
| All Other | 544 | 136 | 25.0% |
| Eliminations | (310) | (141) | Not meaningful |
The distinction between adjusted and GAAP income is visible, not cosmetic. SLB reported $735 million of attributable GAAP net income and $962 million excluding charges and credits. The $227 million difference consists of a $187 million pension settlement charge and $40 million after-tax, after-noncontrolling-interest merger and integration costs. The pension settlement is noncash in the current operating-cash reconciliation. That supports treating it differently from routine operating expenditure, while still recognizing that pension commitments are real obligations.
Pretax segment operating income of $1.576 billion is not the same as consolidated pretax earnings. Corporate and other costs subtract $204 million, corporate interest income adds $22 million, interest expense subtracts $133 million and charges and credits subtract $242 million. The resulting $1.019 billion pretax income is followed by $239 million tax and $45 million attributable to noncontrolling interests, leaving $735 million for SLB. This bridge prevents the most profitable segment measure from being mistaken for common-shareholder earnings.
Adjusted EBITDA margin was 21.88%, approximately 121 basis points below the prior-year 23.08% calculated from reported dollars. Sequentially, the margin improved from the release’s rounded 21.2% to 21.9%. Both statements are true. The improvement supports the recovery thesis, while the annual decline shows that the business is still absorbing a weaker operating environment and changes in mix. Neither comparison should be selected alone merely because it makes a stronger headline.
Tax also affects the apparent earnings gap. The GAAP effective rate was approximately 23.45%, compared with about 19.98% excluding charges and credits. Pension and acquisition accounting influence the denominator and tax treatment. Applying the adjusted rate mechanically to every future charge would be unjustified. Our valuation uses explicitly normalized assumptions and tests them against cash, rather than declaring all excluded costs permanently irrelevant.
| Adjustment | Pretax $M | Net attributable $M | Interpretation |
|---|---|---|---|
| Pension settlement | 187 | 187 | Noncash current charge |
| Merger and integration | 55 | 40 | Tax and NCI affect net amount |
| Total | 242 | 227 | GAAP $735M to adjusted $962M |
| Stock compensation | 72 | Not an EPS exclusion here | Current-quarter cash-flow add-back |
The same nine checks are applied each quarter. Stock compensation was $72 million, or approximately 0.76% of revenue, a relatively modest fraction of the sales base. The adjusted-to-GAAP net-income difference was $227 million, approximately 30.9% of GAAP attributable earnings, making reconciliation material. Below-the-line items include $68 million of interest and other income, of which $25 million was interest income and $43 million earnings from equity-method investments. Those sources should not be described as service revenue.
Noncontrolling interests absorbed $45 million, approximately 5.8% of consolidated net income. SLB owns 70% of OneSubsea, so consolidated operations can create profits that do not all belong to SLB shareholders. The quarter’s entire minority allocation is not assigned to that joint venture without disclosure. The valuation denominator and equity bridge are kept transparent to avoid assuming every consolidated dollar belongs to the common stock.
Nine-month operating cash flow was $3.356 billion, exceeding $2.356 billion consolidated net income. That first conversion test is constructive. After capital investment, however, issuer free cash flow was $1.521 billion, about 66.9% of attributable net income and below the $1.826 billion prior-year figure. Cash must fund equipment, asset-performance investments and exploration data before it can support distributions. EBITDA and operating cash alone do not measure that residual funding capacity.
Ending receivable and inventory proxies were approximately 93.8 and 63.7 days, calculated with a 91-day quarter. These are ending-balance monitoring ratios, not average-balance collection or inventory-cycle measurements. They can be affected by geography, billing milestones, acquisitions and seasonality. The useful question is whether the next filing explains deterioration alongside cash conversion. The ninth check, guidance delivery, remains open for the unchanged approximately $2.5 billion capital-investment plan; we do not fabricate a numerical revenue promise to grade management against.
SLB generated $828 million of third-quarter free cash flow after $485 million of capital expenditures, $114 million of APS investment and $83 million of capitalized exploration data. The three investments total $682 million, deducted from $1.510 billion operating cash flow. During the same quarter, repurchases used $656 million and dividends used $439 million. Distributions therefore exceeded free cash flow by $267 million. The company can fund a temporary difference, but the difference must remain visible when assessing the generosity of its capital-return policy.
The nine-month picture is more demanding. Repurchases of $1.755 billion and dividends of $1.305 billion total $3.060 billion, approximately twice the $1.521 billion free cash generated. The $1.539 billion shortfall is a funding comparison, not a claim that every dollar was borrowed specifically for buybacks. Acquisitions, employee stock proceeds, currency movements and other items also affect debt. The issuer’s complete liquidity bridge shows net debt rising $1.825 billion from year-end to $9.249 billion.
Cash and short-term investments were $3.551 billion against $12.800 billion gross debt. Current liquidity is substantial, but the pending Kelvion acquisition would require approximately $3.4 billion cash and assumption of approximately $0.7 billion debt. The transaction is expected in the first half of 2027, subject to conditions and approvals. It remains an ordinary acquisition of a continuing listed parent, so it does not prevent coverage; it does create an important future funding and integration test.
Capital-investment guidance remains approximately $2.5 billion for 2026. Nine-month investment under that same definition totals $1.835 billion, leaving approximately $665 million if the annual plan is met. This is computed remaining capacity, not a separately issued fourth-quarter forecast. Historical cash is seasonal: the fourth quarter of 2025 generated $2.289 billion of free cash flow. A strong finish could improve the annual funding balance, but repeating that historical amount is an assumption that investors should test rather than quietly bake into a bullish conclusion.
| Balance / commitment | USD millions | Treatment |
|---|---|---|
| Cash +short investments | 3,551 | Reported combined liquidity |
| Gross debt | 12,800 | Current plus long term |
| Net debt | 9,249 | Computed, matches issuer |
| Combined equity | 27,213 | Includes noncontrolling interests |
| Total assets | 56,200 | Issuer overrides provider error |
| Kelvion cash consideration | 3,400 | Pending, approximate |
| Kelvion debt assumed | 700 | Pending, approximate |
Our earnings route assumes normalized EPS of $3.10 and a seventeen-times multiple, producing $52.70 per share. The EPS assumption is close to the retrieved 2027 consensus of $3.133, but it remains our normalized-cycle input. The multiple reflects a diversified industrial and energy-service business with valuable digital and production capabilities, alongside cyclicality and integration risk. It does not assign a software multiple to the whole company because one activity serves data centers.
The enterprise-value route assumes $8.5 billion of normalized EBITDA at ten times, subtracts $9.249 billion current net debt, then divides by 1.497 billion diluted weighted-average shares. It produces $50.60 per share. That route uses an explicit share denominator rather than silently switching between period-end shares and the provider’s market capitalization. It is a simplified debt-and-cash bridge; operating leases and minority interests are not separately capitalized, so it should not be compared uncritically with an enterprise multiple that includes those claims.
The cash route models annual enterprise cash flows of $4.3 billion, $4.8 billion, $5.2 billion, $5.5 billion and $5.8 billion, discounted at 9% with 2.5% terminal growth. After the same net-debt and share bridge, the result is $46.67. The cash sequence is an analyst assumption that recognizes future reinvestment. It is not management guidance, and the issuer’s historical levered free cash flow is a reasonableness reference rather than being relabeled mechanically as unlevered cash. The three-route average is approximately $49.99, rounded to $50.
At $53.08, the same seventeen-times framework requires about $3.12 sustainable EPS. The ten-times framework implies approximately $8.871 billion EBITDA. A steady-state 9% discount and 2.5% growth model implies approximately $5.625 billion annual enterprise cash flow. Those hurdles are plausible only if recovery turns into durable economics. Kelvion’s future earnings are not invented or capitalized here; a debt-only $4.1 billion funding stress would reduce value by about $2.74 per share before any acquired earnings. That is a sensitivity, not a valuation of the transaction.
| Route | Arithmetic | Value |
|---|---|---|
| Earnings | $3.10 ×17 | $52.70 |
| EV / EBITDA | ($8,500M ×10 −$9,249M) /1,497M | $50.60 |
| Cash flow | Five annual cash flows;9% discount;2.5% terminal growth | $46.67 |
| Base anchor | Equal-weight mean≈$49.99, rounded | $50.00 |
The retrieved FMP target consensus is $63.92, with a $54–$71 range. Its ratings collection shows 56 Buy, six Hold and four Sell observations. Those counts are provider records, not a claim that 66 independent analysts all published new opinions after this quarter. Aggregate targets can mix dates and horizons, so the specific recent records are more useful for evaluating what changed around the release.
Two October 26 records point in different directions. Piper Sandler raised its target to $65 from $63, while Barclays lowered its target to $63 from $66. Both are above our $50 anchor, even though one increased and the other decreased. That is a better description of the Street response than declaring a uniform upgrade cycle. The source is the dated FMP news-target feed; we have not read those firms’ complete proprietary research notes and do not invent their reasoning.
The annual estimate snapshot gives approximately $36.929 billion revenue and $2.441 EPS for 2026, and $40.037 billion revenue with $3.133 EPS for 2027. The 2027 EPS figure has sixteen contributing analysts in the returned record. These estimates imply meaningful improvement after current-year pressure. They are consensus context, not SLB guidance. The release’s explicit capital-investment plan should not be blended with consensus revenue into a fictitious company forecast.
Our disagreement is mainly about the price paid for recovery and the cash claims competing for it. A stronger Middle East rebound, offshore execution and digital expansion could justify higher estimates. A large acquisition can also add revenue without automatically increasing per-share value. We require evidence that profit and cash improve after integration and funding costs. A target above the share price is not sufficient evidence that those costs have already been recovered.
| Source | Date | Target | Change / context |
|---|---|---|---|
| Piper Sandler via FMP | 2026-10-26 | $65 | Raised from$63 |
| Barclays via FMP | 2026-10-26 | $63 | Lowered from$66 |
| FMP aggregate | Retrieved2026-10-27 | $63.92 | Mixed-vintage target consensus |
| Charged Alpha | 2026-10-27 | $50 | HOLD; three-route anchor |
| Year | Revenue consensus $B | EPS consensus | Status |
|---|---|---|---|
| 2026 | 36.929 | 2.441 | Provider estimate |
| 2027 | 40.037 | 3.133 | Provider estimate,16 EPS analysts |
| 2026 capital investment | ≈2.500 | Not applicable | Actual issuer guidance |
Management deserves credit for a sequential improvement across the major core divisions. Middle East revenue increased 13% from the prior quarter despite renewed disruptions late in the period, and offshore activity supported other regions. The evidence shows operational recovery from a difficult base. It does not establish that geopolitical disruption has ended or that every geography has returned to its previous earnings power. We grade the recovery as progress while retaining the annual-comparison margin test.
Capital allocation is the more demanding part of the scorecard. The company repurchased 12.9 million shares for $656 million in the quarter, an implied average of approximately $50.85 per share. Across nine months, 34.0 million shares cost $1.755 billion, or about $51.62 per share. Those averages are computed from rounded issuer totals. They are close to our valuation anchor, so the purchases cannot be called obviously cheap merely because management chose to execute them.
The annual report documents a $10 billion authorization approved in 2016, with $5.9 billion cumulatively used through year-end 2025. Authorization is capacity, not a requirement to spend regardless of price. The board approved the current $0.295 quarterly dividend, payable January 7, 2027 to holders of record December 2, 2026. Annualizing that rate gives $1.18, approximately a 2.22% yield at the reference price, subject to future declarations.
SLB is a Curaçao parent with NYSE-listed common shares rather than an ADR requiring a depositary ratio. PricewaterhouseCoopers LLP is the auditor. The annual reports show approximately 111,000 employees in 2023, 110,000 in 2024 and 109,000 in 2025. No single customer exceeded 10% of consolidated revenue in those years, although geographic and national-oil-company exposure remains economically important. These facts frame the governance and operating context; they are not substitutes for measuring returns on the next acquisition.
| Area | Evidence | Assessment |
|---|---|---|
| Operating recovery | Core divisions grow sequentially | Progress; annual margins still weaker |
| Capital plan | FY investment≈$2.5B retained | Await full-year delivery |
| Buybacks | Quarter implied average$50.85 | Near our anchor; price discipline matters |
| Funding | YTD distributions exceed FCF$1.539B | Watch annual close and net debt |
| Kelvion | Cash$3.4B +debt$0.7B | Pending return/integration test |
| Year | Employees | SBC $M | Issuer FCF $M |
|---|---|---|---|
| 2023 | 111,000 | 293 | 4038 |
| 2024 | 110,000 | 316 | 3990 |
| 2025 | 109,000 | 332 | 4115 |
The leading operating risk is that the sequential recovery stalls before margins regain their prior-year level. Middle East conflict, project disruption and customer budget changes can affect both activity and collection. Offshore awards improve visibility but do not eliminate execution costs or the timing between booking, delivery and cash. We assign this risk High potential impact, while avoiding a fabricated probability for a specific geopolitical outcome.
The second risk is capital-allocation congestion. Buybacks, dividends, ordinary reinvestment and Kelvion all make claims on cash. Each can be reasonable on its own; together they can leave less balance-sheet room if the recovery disappoints. The current net-debt increase is not proof of distress, but it makes the next cash bridge consequential. A business can report positive earnings and still reduce financial flexibility through the timing of its investments and distributions.
Third is paying for a data-center narrative ahead of disclosed economics. The 76% year-over-year revenue increase is strong, and thermal management could broaden the offering. Yet the release does not provide a complete standalone Data Center Solutions income statement. We cannot infer high software-like margins or guaranteed synergies from its growth rate. Integration, manufacturing execution, customer concentration within the new activity and the acquisition price all remain important questions.
The strongest bull case combines renewed Middle East activity, offshore backlog conversion, production optimization and expanding recurring digital workflows. That combination can raise earnings while smoothing some drilling cyclicality. The strongest bear case is that acquired revenue masks weak underlying growth, margins remain below historical levels, and cash obligations expand before returns arrive. Our $35 bear, $50 base and $74 bull cases make that range visible. Probabilities of 25%, 50% and 25% are our assumptions, not frequencies derived from a statistical model.
| Rank | Risk | Likelihood / exposure | Impact | Evidence to watch |
|---|---|---|---|---|
| 1 | Activity and geopolitical interruption | Elevated exposure | High | Core margins and regional revenue |
| 2 | Cash allocation and leverage | Current funding gap | High | FCF, distributions and net debt |
| 3 | Kelvion integration / price | Pending transaction | High | Closing terms and disclosed returns |
| 4 | Data-center execution | Fast growth, limited profit disclosure | Medium–high | Absolute revenue/profit and cash |
| 5 | Working capital and minority claims | Ongoing | Medium | Receivables, NCI and collections |
The next quarterly release should show whether the sequential rebound becomes a stronger annual comparison. We will look for acquisition-excluded revenue growth above 3%, rather than merely another acquisition-assisted headline. That threshold is our analytical test; it is not guidance. A flat or negative underlying comparison would weaken the case that broad activity is accelerating. The same comparison base must be used before grading it.
Profitability needs a separate test. A consolidated adjusted EBITDA margin at or above 23% would suggest that mix and operating leverage are restoring more of the lost profitability. A result below 21% would be adverse evidence unless management provides a specific, well-supported timing explanation. Production Systems strength should be assessed alongside Reservoir Performance and Well Construction so one division does not conceal persistent weakness in the rest of the portfolio.
Cash is the decisive capital-allocation checkpoint. We will compare full-year free cash with dividends and repurchases, explain any shortfall using the issuer liquidity bridge, and track net debt against the current $9.249 billion. A quarter in which free cash covers distributions and debt stabilizes would support flexibility ahead of Kelvion. A further rise above $10 billion combined with weaker cash and margins would warrant a lower valuation or more caution. These are research thresholds, not loan covenants.
For scheduling, the next full-year reporting cycle is a January 2027 review window. We have not independently confirmed a future earnings-release date here. The dividend record and payment dates are issuer-confirmed; the Kelvion closing expectation is the first half of 2027 and remains conditional. We do not invent a prior packet signpost grade: the locally available prior Q2 material establishes the published angle, but does not supply a canonical research-packet scorecard for this comparison.
| Signpost | Now | Green threshold | Red threshold | Next check |
|---|---|---|---|---|
| Acquisition-excluded revenue | ≈2% YoY | >3% on same basis | ≤0% | Q4 release /Jan2027 review |
| Adjusted EBITDA margin | 21.9% | ≥23% | <21% | Q4 release /Jan2027 review |
| FCF versus distributions | $828M vs$1,095M Q3 | FCF covers distributions | Widening funding gap | FY release /Jan2027 review |
| Net debt | $9.249B | ≤$9.249B with stronger cash | >$10B plus weaker margins | FY release /Jan2027 review |
| Capital investment | $1.835B YTD | FY≈$2.5B explained | Material unexplained overrun | FY release /Jan2027 review |
| Digital ARR | $1.04B | >10% reported annual growth | <5% annual growth | Q4 release /Jan2027 review |
| Kelvion | Pending H1 2027 | Disclosed return/funding plan | Cost rise or weak return case | Before closing /H1 2027 |
The current quarter is the period ended September 30, 2026, reported in the October 23 SEC Form 8-K and Exhibit 99. The latest available quarterly Form 10-Q in the reviewed submissions was for June 30; the absence of a current Q3 10-Q does not prevent use of the complete released results. Historical earnings exhibits provide nine quarterly records from Q3 2024 through Q3 2026. Annual reports provide three years of cash, compensation and employee context. Dated FMP responses supply market prices, estimates, ratings and historical statement fields.
Several normalization choices matter. The current provider balance sheet omitted assets and misclassified liabilities, producing totals that did not agree with the release. We replaced those totals with the primary statement: assets $56.200 billion, liabilities $28.987 billion and combined equity $27.213 billion. The current release does not split the last figure between parent and noncontrolling equity, so no such split is fabricated. Historical raw provider fields remain preserved for audit, while the packet’s conclusions use the corrected source-bound dataset.
Free cash flow follows SLB’s definition: operating cash less capital expenditures, APS investments and capitalized exploration data. A provider series that subtracts a different set of investments is not used as if it were the same metric. Segment history also requires care: the earlier Digital and Integration division was subsequently separated into Digital and other activities. Historical original division rows remain available, but we do not connect unlike labels into a supposedly comparable growth series. Current-period comparisons use the issuer’s recast presentation.
All growth rates, margin changes, working-capital proxies, funding gaps and valuation values are calculated in the saved analysis workflow. Dollar charts marked millions use dollar-million formatting; per-share valuation charts use ordinary dollars. Model assumptions are separated from issuer guidance, and unknown values remain unavailable. This discipline makes the call revisable: the next filing can change the assumptions without requiring the historical facts or the current publication to be silently rewritten.
| Quarter | Revenue $M | GAAP EPS | Adjusted EPS | Issuer FCF $M |
|---|---|---|---|---|
| Q3 2024 | 9,159 | 0.83 | 0.89 | 1,805 |
| Q4 2024 | 9,284 | 0.77 | 0.92 | 1,631 |
| Q1 2025 | 8,490 | 0.58 | 0.72 | 103 |
| Q2 2025 | 8,546 | 0.74 | 0.74 | 622 |
| Q3 2025 | 8,928 | 0.50 | 0.69 | 1,101 |
| Q4 2025 | 9,745 | 0.53 | 0.78 | 2,289 |
| Q1 2026 | 8,721 | 0.50 | 0.52 | −23 |
| Q2 2026 | 8,972 | 0.52 | 0.55 | 716 |
| Q3 2026 | 9,449 | 0.49 | 0.64 | 828 |
| Source | Material | Role |
|---|---|---|
| Current filing | 8-K0001193125-26-429435 /Ex99 | Current results and transaction disclosures |
| Annual report | 2025 10-K;2024/2023 annual reports | Structure, cash and workforce |
| Historical SEC exhibits | Q3 2024 through Q3 2026 | Nine quarters and reconciliations |
| FMP snapshot | Retrieved October27;quote October26 | Prices, targets, estimates and statements |
| Computed model | Saved episode data and calculations | Transparent derived values and assumptions |
Current SEC earnings release · FY2025 annual report · Issuer release